RFP–Navigating the New Era of Molecularly-Defined Care in Alzheimer’s Disease: Applying Nuclear Medicine to Quantify Neuropathology and Improve Diagnostic Accuracy in the Earliest Stages of the AD Continuum

Drzezga, Alexander

guest :: login JuSER
		Search		Submit		Personalize Your alerts Your baskets Your searches		Help

Home > Publications database > RFP–Navigating the New Era of Molecularly-Defined Care in Alzheimer’s Disease: Applying Nuclear Medicine to Quantify Neuropathology and Improve Diagnostic Accuracy in the Earliest Stages of the AD Continuum

Conference Presentation (Other)

FZJ-2024-01303

RFP–Navigating the New Era of Molecularly-Defined Care in Alzheimer’s Disease: Applying Nuclear Medicine to Quantify Neuropathology and Improve Diagnostic Accuracy in the Earliest Stages of the AD Continuum

Drzezga, A.FZJ*

2023

SNMMI Congress, Chicago, USA, 25 Jun 2023 - 25 Jun 2023

Contributing Institute(s):

Molekulare Organisation des Gehirns (INM-2)

Research Program(s):

Appears in the scientific report 2023

Click to display QR Code for this record

The record appears in these collections:
Document types > Presentations > Conference Presentations
Institute Collections > INM > INM-2
Workflow collections > Public records
Publications database

Record created 2024-01-31, last modified 2024-02-26

Similar records

Rate this document:

(Not yet reviewed)

Add to personal basket
Export as Author List with IDs BibTeX (UTF-8), EndNote XML, EndNote Text, RIS, MARC, Print MARC, MARCXML, DC,
Request correction
Submit fulltext